Cardinal Partners


	Long-Term Study of Middle-Aged Mice Shows Resveratrol Improves Health and Mimics Some Benefits of Dietary Restriction
	July 03, 2008
	Cubist to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V.
	July 02, 2008
	Cubist to Announce 2Q08 Financial Results on July 17, 2008
	July 01, 2008
	Cubist Testifies on Need to Encourage Antibiotic Research and Development
	June 24, 2008
	Cubist Appoints Mark H.N. Corrigan, M.D., to its Board of Directors
	June 24, 2008
	Alnylam and Kyowa Hakko Form Alliance for the Development and Commercialization of ALN-RSV01 in Asia
	June 19, 2008
	athenahealth Appoints New General Counsel
	June 19, 2008
	Cubist Appoints Nancy J. Hutson, Ph.D., to its Board of Directors
	June 16, 2008
	Wayne State University Physician Group Selects athenahealth's Centrally-Hosted Practice Management Services
	June 05, 2008
	GLAXOSMITHKLINE SUCCESSFULLY COMPLETES TENDER OFFER FOR SHARES OF SIRTRIS PHARMACEUTICALS
	June 02, 2008
	Aetna Ranks First in 2008 PayerView(SM) Ranking; Pays Medical Providers the Fastest Among National Commercial Insurers
	May 29, 2008
	athenahealth to Release 2008 PayerView(SM) Rankings
	May 28, 2008
	Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
	May 27, 2008
	Alnylam and Collaborators Publish In Vivo Research on Validation of a Mammalian Host Gene Involved in Malaria Infection and on the Anti-Parasitic Efficacy of RNAi Therapeutics
	May 13, 2008
	Alnylam Pharmaceuticals Reports First Quarter 2008 Financial Results
	May 08, 2008
	Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2008
	May 07, 2008
	Rib-X Pharmaceuticals, Inc. Appoints Nancy Motola as Senior Vice President of Regulatory Affairs
	May 06, 2008
	athenahealth, Inc. Reports First-Quarter 2008 Results
	May 06, 2008
	Regulus Therapeutics Exclusively Licenses Intellectual Property from Stanford University Relating to microRNA Antagonists to Treat Inflammatory Diseases
	May 06, 2008
	Thomson Reuters and Lance Armstrong Foundation Provide Online Cancer Information
	May 06, 2008
	GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
	May 02, 2008
	Connecticut State Medical Society Joins with athenahealth to Offer On-Demand Practice Management Services to Physicians Statewide
	May 02, 2008
	Sirtris Pharmaceuticals Reports First Quarter 2008 Financial Results
	May 01, 2008
	Momenta Pharmaceuticals Receives Regulatory Guidance On M-Enoxaparin ANDA
	April 29, 2008
	GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development
	April 22, 2008
	Alnylam Initiates Phase II Trial to Evaluate Safety and Tolerability of ALN-RSV01 in Adult Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus (RSV) Infection
	April 09, 2008
	athenahealth, Inc. Reports Fourth-Quarter and Full-Year 2007 Results
	March 05, 2008
	Sirtris Pharmaceuticals' SRT501 Slows Retinal Ganglion Cell Loss During Optic Neuritis in a Preclinical Model of Multiple Sclerosis
	March 04, 2008
	Thomson Healthcare Cancer Profiler used in study
	March 03, 2008
	athenahealth Awarded Community Health Systems Contract
	February 27, 2008
	Sirtris Pharmaceuticals Reports Fourth Quarter and 2007 Financial Results; Significant Progress Achieved
	February 25, 2008
	Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2007
	February 14, 2008
	Leonard P. Guarente, a Founder of the Sirtuin Field, Signs Exclusive Consulting Agreement with Sirtris Pharmaceuticals
	February 05, 2008
	Thomson Healthcare online treatment tools mark milestone
	February 02, 2008
	athenahealth's National Physician Network Live With New Centers for Medicare and Medicaid Services Pay-For-Performance Measures
	January 29, 2008
	Alnylam Announces Grant of New Patent Covering RNAi Therapeutics in the United Kingdom
	January 28, 2008
	AccentCare Newport Beach Ranked Among the Top 25 Percent of Home Health Providers in the Country for 2007
	January 23, 2008
	Cubist Pharmaceuticals Reports GAAP Diluted Net Income of $0.16 Per Share in Fourth Quarter 2007 and GAAP Diluted Net Income of $0.85 Per Share for Full Year 2007
	January 23, 2008
	Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
	January 04, 2008
	Cubist Pharmaceuticals Acquires Illumigen Biosciences
	December 26, 2007
	athenahealth Announces Senior Management Addition and Changes
	December 14, 2007
	Sirtris Pharmaceuticals' SIRT1 Activator Controls Glucose as well as a DPP-4 inhibitor in a Pre-Clinical Model of Type 2 Diabetes
	December 13, 2007
	Sirtris and Harvard Unveil Promising, Novel SIRT1 Activators for Treating Diseases of Aging; Therapeutic Type 2 Diabetes Data Published in the Journal Nature
	November 28, 2007
	Alnylam Announces Grant of Broad Patent Covering RNAi Therapeutics in Germany
	November 26, 2007

Current Portfolio News

Archive Portfolio News